Inhibitor Therapeutics
Insider Trades
Paul D'Sylva sold 19,100 shares of INTI on 19 January. They now own 271,216 INTI shares, or a 7% holding decrease.
Paul D'Sylva sold INTIW. Mark Watson bought 10,000 shares of INTI on 8 September. They now own 10,000 INTI shares, or a Infinity% holding increase.
W. Mark Watson bought INTIFrancis E Odonnell JR bought 20,000,000 shares of INTI on 10 September. They now own 20,000,000 INTI shares, or a Infinity% holding increase.
Francis E Odonnell JR bought INTIHedgePath LLC sold 20,000,000 shares of INTI on 10 September. They now own 84,687,069 INTI shares, or a 19% holding decrease.
HedgePath LLC sold INTIFrancis E Odonnell JR sold 2,560,000 shares of INTI on 15 June. They now own 11,440,000 INTI shares, or a 18% holding decrease.
Francis E Odonnell JR sold INTIStefan Cross sold 600,000 shares of INTI on 19 December. They now own 0 INTI shares, or a 100% holding decrease.
Stefan Cross sold INTIMayne Pharma International Pty Ltd bought 8,695,653 shares of INTI on 10 January. They now own 3,478,261 INTI shares, or a 167% holding increase.
Mayne Pharma International Pty Ltd bought INTIMayne Pharma Ventures Pty Ltd bought 5,797,103 shares of INTI on 5 July. They now own 5,797,102 INTI shares, or a 579710300% holding increase.
Mayne Pharma Ventures Pty Ltd bought INTI